Suppr超能文献

miR-202-3p 作为一种肿瘤抑制因子,可降低甲状腺乳头状癌中的细胞迁移和侵袭。

MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.

机构信息

Department of General surgery, Affiliated Haian Hospital of Nantong University, Haian County of Nantong City, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1145-1150. doi: 10.26355/eurrev_201902_17005.

Abstract

OBJECTIVE

MicroRNAs (miRNAs) are recently identified as key regulators of tumor development and progression. MiR-202-3p functions as tumor suppressor in some cancer types. The aim of the study is to determine its expression pattern and explore the functions underlying the mechanism of miR-202-3p in papillary thyroid carcinoma (PTC).

PATIENTS AND METHODS

By using quantitative RT-PCR (QRT-PCR) analyses, we detected miR-202-3p expression in PTC tissues and cell lines. Transwell migration and invasion assays were performed to measure the migration and invasion ability of tumor cells transfected with miR-202-3p mimic. Western blot analysis was used to detect the protein expression.

RESULTS

Our results showed that miR-202-3p expression was frequently downregulated in 96 cases PTC tissues compared to adjacent normal tissues. Lower expression of miR-202-3p associated with lymph node metastasis of patients with PTC. Overexpression of miR-202-3p inhibited cell migration and invasion in TPC-1 and BCPAP cells. Furthermore, enforced expression of miR-202-3p inhibited WNT signaling by downregulating β-catenin expression in TPC-1 and BCPAP cells.

CONCLUSIONS

Our findings indicated that miR-202-3p may represent a novel therapeutic target of in PTC.

摘要

目的

微小 RNA(miRNAs)最近被鉴定为肿瘤发生和发展的关键调节因子。miR-202-3p 在某些癌症类型中作为肿瘤抑制因子发挥作用。本研究旨在确定其表达模式,并探讨 miR-202-3p 在甲状腺乳头状癌(PTC)中的作用机制。

患者和方法

通过使用定量 RT-PCR(QRT-PCR)分析,我们检测了 PTC 组织和细胞系中 miR-202-3p 的表达。通过 Transwell 迁移和侵袭实验测量转染 miR-202-3p 模拟物的肿瘤细胞的迁移和侵袭能力。使用 Western blot 分析检测蛋白表达。

结果

我们的结果表明,与相邻正常组织相比,96 例 PTC 组织中 miR-202-3p 的表达经常下调。miR-202-3p 表达较低与 PTC 患者的淋巴结转移有关。miR-202-3p 的过表达抑制了 TPC-1 和 BCPAP 细胞的迁移和侵袭。此外,在 TPC-1 和 BCPAP 细胞中,强制表达 miR-202-3p 通过下调β-catenin 表达抑制了 WNT 信号通路。

结论

我们的研究结果表明,miR-202-3p 可能是 PTC 的一种新的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验